Cyclooxygenase-2 contributes to diabetic nephropathy through glomerular EP4 receptor.

Guan, Yi; Davis, Linda; Breyer, Matthew D; Hao, Chuan-Ming

Guan, Yi; Davis, Linda; Breyer, Matthew D; Hao, Chuan-Ming.

Afiliação

Guan Y; Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
Davis L; Department of Medicine, Division of Nephrology, Vanderbilt University, Nashville, TN, United States.
Breyer MD; Biotechnology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46225, USA.
Hao CM; Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China; Department of Medicine, Division of Nephrology, Vanderbilt University, Nashville, TN, United States. Electronic address: chuanminghao@fudan.edu.cn.

Prostaglandins Other Lipid Mediat ; 159: 106621, 2022 04.

Article em En | MEDLINE | ID: mdl-35131551

Assuntos

Diabetes Mellitus Experimental; Nefropatias Diabéticas; Albuminúria; Animais; Ciclo-Oxigenase 2; Inibidores de Ciclo-Oxigenase 2; Diabetes Mellitus Experimental/complicações; Dinoprostona; Células Endoteliais; Feminino; Humanos; Masculino; Camundongos; Camundongos Endogâmicos DBA; Prostaglandinas; Receptores de Prostaglandina E Subtipo EP4

Palavras-chave

Cyclooxygenase-2; Diabetic nephropathy; EP4 receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Nefropatias Diabéticas Limite: Animals / Female / Humans / Male Idioma: En Revista: Prostaglandins Other Lipid Mediat Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google